Back to Search Start Over

Early clinical experience with imatinib in COVID-19: Searching for a dual effect.

Authors :
Morales-Ortega A
Rivas-Prado L
Frutos-Pérez B
Jaenes-Barrios B
Farfán-Sedano AI
García-Parra CJ
Hernández-Muniesa B
Duarte-Millán MÁ
Madroñal-Cerezo E
Ontañón-Nasarre A
Ruiz-Giardín JM
Bermejo F
García-Gil M
Gonzalo-Pascua S
San Martín-López JV
Bernal-Bello D
Source :
The Journal of infection [J Infect] 2021 May; Vol. 82 (5), pp. 186-230. Date of Electronic Publication: 2021 Feb 05.
Publication Year :
2021

Abstract

Competing Interests: Declaration of Competing Interests David Bernal-Bello is the principal investigator of a non-sponsored randomised trial investigating the therapeutic role of imatinib and baricitinib in COVID-19 patients (NCT04346147). The rest of the authors are sub-investigators in this project. All authors declare no other competing interests.

Details

Language :
English
ISSN :
1532-2742
Volume :
82
Issue :
5
Database :
MEDLINE
Journal :
The Journal of infection
Publication Type :
Editorial & Opinion
Accession number :
33549625
Full Text :
https://doi.org/10.1016/j.jinf.2021.02.002